Science to Business: The AI Revolution - Disrupting the Path from Drug Discovery to Patient Care

NovemberNov 07 2018

hours
- hours
- days
- weeks

Science to Business Network Presents...

The AI Revolution: Disrupting the Path From Drug Discovery to Patient Care

Artificial intelligence (AI) in healthcare involves the use of algorithms and software to mimic human cognition in analyzing complex medical data. It has the potential to transform every step of the path from drug discovery to patient care by increasing efficiency and effectiveness, while decreasing cost. Are we on the cusp of an AI revolution? During this session, experts from leading AI companies will profile the current state of AI in healthcare, review the challenges and opportunities facing this burgeoning sector, and discuss how Canada can leverage its research infrastructure to become a world leader in AI technology.

Session Objectives

Profile how AI is disrupting business areas from drug discovery to patient diagnosis and treatment
Discuss the challenges and opportunities in unleashing the power of AI while balancing data integrity, privacy, and a complex regulatory environment
Explore how Canada can leverage its public and private research infrastructure to become a global leader in AI

Host: Bruce Seet, Ph.D, MBA
With Guest Panelists:

Simon Smith (Chief Growth Officer, BenchSci)
Naheed Khurji (President and CEO, Cyclica)

John Reeves (Partner, Chief Medical Officer, conversationHEALTH)

Wednesday, Nov. 7th, 2018

Brassaii

461 King St W, Toronto

6:00 pm Event Registration + Networking (cash/credit bar)
6:30 pm Panel Discussion + Q&A

7:30 pm Networking Reception (light snacks provided - cash/credit bar)

Early Bird Online Tickets (Eventbrite):

Member - $5

Non-member (student) - $15

Non-member (industry professional) - $20

At the Door Ticket Prices:

Member - $10

Non-member - $30

Note: online processing fees not included.

**Memberships - NEW for 2018/2019**

2018 - 2019 Membership Fee (student) - $40

2018 - 2019 Membership Fee (industry professional) - $75

As an S2BN Member, you will join a community of like-minded academics and professionals who strive to improve health and life sciences innovation in Canada. Working together, we will play an essential role in building bridges between academia, government and industry, and fostering the development of future leaders in Canada's life and health sciences sector.

Your membership will help support S2BN's mission of delivering quality events and novel programs to the S2BN community.

Members will receive:

Discounted entry to any S2BN event across Canada
Priority registration
Access to an S2BN members-only networking event

Please note: Memberships are non-transferable and valid from Sept. 2018 - Aug. 2019.

Panelist Biographies:

Simon Smith

Simon has a Bachelor of Journalism from Ryerson University and a Master of Arts in the History and Philosophy of Science and Technology from the University of Toronto.

Simon has spent 17 years straddling business strategy, marketing and technology in life science-focused startups and agencies. Immediately prior to BenchSci, he led digital marketing initiatives for pharmaceutical and biotechnology companies as SVP, Strategy with Klick Health. He’s passionate about (and a bit obsessed with) scaling innovative solutions to meaningful problems.

Naheed Kurji

Naheed is the President and CEO of Cyclica, a Toronto-based, ventured-backed biotech that is driving drug discovery by empowering scientists in pharma with a cloud-based and AI-augmented platform to enhance how they design, screen, and personalize medicines.

John Reeves

Within a year of entering clinical practice in 1994, Dr. Reeves recognized the potential of the Internet to transform the doctor - patient relationship and founded the world's first digital health agency - which he ultimately sold to REED ELSEVIER in 2000.

Dr. Reeves has since held senior digital leadership roles with both ELSEVIER and McCann Health in NY - where he led digital health strategy across the network's 75 agencies. John returned to Toronto in 2010 and has since focused his efforts on disrupting healthcare through hacking, incubation, and accelerator programs.

One start up that caught his eye over the past few years was emojiHEALTH - which was founded 3 years ago by his then 16 year old daughter Alexandra. emojiHEALTH is a chat bot designed to activate teens to better manage their health - and when relevant - their conditions. Over the past 2 years John has extended the learnings and insights from emojiHEALTH to a fast growing start up called conversationHEALTH - which has quickly grown to almost 25 FTEs and is now delivering conversational AI solutions to the world's largest Pharma brands.

Host Biography:

Bruce Seet, PhD, MBA

Bruce Seet is the founder and President of the Science to Business Network, a group dedicated to bridging academia, government and industry. He started his career in bio-pharmaceuticals in 2006 and held multiple roles at GlaxoSmithKline over 8 years. Since 2014, he has been Director, Medical Affairs, at Sanofi Pasteur Canada. He also holds the position of Adjunct Professor at the University of Toronto's Department of Molecular Genetics. Bruce earned a B.Sc (Honours Human Physiology) and a Ph.D. (Microbiology and Immunology) from Western University (London, Canada), followed by a postdoctoral research fellowship at the Lunenfeld Research Institute at Mt. Sinai Hospital (Toronto).

Visit Website

Event expired

Event is in progress

Location

Brassaii 461 King St W, Toronto

Directions

Get Directions

Could not find route!